Patent Application
Provisional
Small
App. No. 63/329,867
· Confirmation No. 1005
Treatment of Arginase 1 Deficiency
Inventor:
Anthony G. Quinn
Applicant:
Aeglea BioTherapeutics, Inc.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2023-04-14 | PA.. |
Power of Attorney | 3 | View | |
| 2023-04-14 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-04-21 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2022-04-11 | APPENDIX |
Appendix to the specification | 2 | View | |
| 2022-04-11 | ADS |
Application Data Sheet | 8 | View | |
| 2022-04-11 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-04-11 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2022-04-11 | CLM |
Claims | 2 | View | |
| 2022-04-11 | SPEC |
Specification | 57 | View |
Inventors
Anthony G. Quinn
Gloucester, MA
Attorneys & Agents of Record
Prosecution
- Customer No.
- 48394
- Docket No.
- A0025-00-B1
- Confirmation No.
- 1005
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/329,867
- Filed
- 2022-04-11
External Links